Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
IncomeQ Nasdaq-100 Premium Income ETF
Titan Acquisition Corp. - Class A Ordinary Shares
Titan Acquisition Corp. - Warrants
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by Aurigene Oncology Limited
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
December 02, 2025
From
Aurigene Oncology Limited
Via
Business Wire
Tickers
RDY
Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025
October 22, 2025
From
Aurigene Oncology Limited
Via
Business Wire
Tickers
RDY
Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
October 08, 2024
From
Aurigene Oncology Limited
Via
Business Wire
Tickers
RDY
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.